The once-weekly schedule is practical for long-term use
Clinical trials have demonstrated Liraglutide's ability to lower HbA1c levels by up to 25.5% on an average, with weight loss of 2-3 kg observed as an added benefit
Cave MC, Hurt RT, Frazier TH, Matheson PJ, Garrison RN, McClain CJ, McClave SA: Obesity, inflammation, and the potential application of pharmaconutrition
The Supreme Courts Actavis decision established that reverse payment settlements are subject to antitrust rule-of-reason analysis, making them risky enough that straightforward cash payments from brand to generic have largely disappeared from settlement practice
You wont get any guidance
M.CordeiroC